糖尿病对急性心肌梗死患者直接经皮冠状动脉介入治疗后左心室重构的影响

被引：17

作者：

张奇

张瑞岩

胡健

杨震坤

丁风华

朱天奇

朱政斌

沈卫峰

机构：

[1] 上海交通大学医学院附属瑞金医院心脏科

来源：

中国介入心脏病学杂志 | 2014年 / 22卷 / 05期

关键词：

心肌梗死; 经皮冠状动脉介入治疗; 左心室重构; 糖尿病;

D O I：

暂无

中图分类号：

R542.22 [];

学科分类号：

1002 ; 100201 ;

摘要：

目的心肌梗死后左心室重构与患者的临床预后密切相关,本研究旨在探讨糖尿病对急性ST段抬高心肌梗死(STEMI)患者直接经皮冠状动脉介入治疗(PCI)后左心室重构的影响。方法单中心、前瞻性入选STEMI接受急诊PCI的患者451例,其中糖尿病患者93例,非糖尿病患者358例。比较糖尿病组与非糖尿病组患者的一般临床情况、造影和介入治疗结果、术后1周和6个月心超随访左心室重构及不良心脏事件发生率。结果与非糖尿病组比较,糖尿病组患者症状至就诊时间显著延长[(399±106)min比(321±116)min,P=0.006],多支血管病变比例增高(65.6%比51.7%,P=0.02),但两组住院期左心功能相似。PCI后6个月心超随访发现,糖尿病组患者左心室重构比例明显高于非糖尿病患者(29.0%比17.3%,P=0.01)。糖尿病(RR 2.10,95%CI 1.31-4.79,P=0.02)、前壁心肌梗死(RR 2.13,95%CI 1.31-4.19,P=0.03)及多支血管病变(RR 2.85,95%CI1.73-4.67,P=0.01)是STEMI患者发生左心室重构的独立预测因素。临床随访显示,糖尿病组患者因心力衰竭诊断而再次住院的比例增加(12.9%比8.1%,P=0.15)。左心室重构患者(23/89例)发生不良临床事件比例显著高于无左心室重构患者(25.8%比6.6%,P<0.001)。结论糖尿病是急性STEMI患者急诊PCI后发生左心室重构的高危因素,因此,制定糖尿病STEMI患者的综合干预策略,可能有助于进一步改善其预后。

引用

页码：283 / 287

页数：5

共 16 条

[1] 血运重建治疗对冠心病合并心力衰竭患者预后的影响 [J].

薛增明 ;

马长生 ;

刘新民 ;

康俊萍 ;

聂绍平 ;

董建增 .

中国介入心脏病学杂志, 2012, 20 (05) :256-261

[2]

慢性心力衰竭诊断治疗指南[J]. 中华心血管病杂志. 2007(12)

[3] 急性心肌梗死存活心肌对左室重构影响的临床研究 [J].

葛雷 ;

钱菊英 ;

祝文虎 ;

樊冰 ;

程蕾蕾 ;

冯琪 ;

王灏 ;

蔡乃绳 ;

葛均波 .

中国介入心脏病学杂志, 2003, (04) :35-38

[4]

Beneficial effects of intracoronary tirofiban bolus administration following upstream intravenous treatment in patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: The ICT-AMI study[J] . Tian Qi Zhu,Qi Zhang,Jian Ping Qiu,Hui Geng Jin,Lin Lu,Jie Shen,Liang Ping Zhao,Rui Yan Zhang,Jian Hu,Zhen Kun Yang,Wei Feng Shen.International Journal of Cardiology . 2011

[5] Effects of β-blockers on glucose and lipid metabolism [J].

Fonseca, Vivian A. .

CURRENT MEDICAL RESEARCH AND OPINION, 2010, 26 (03) :615-629

[6]

Comparison of Effects of Primary Coronary Angioplasty on Left Ventricular Remodeling and Heart Failure in Patients <70 Versus ≥70 Years With Acute Myocardial Infarction[J] . Nazario Carrabba,Guido Parodi,Renato Valenti,Angela Migliorini,David Antoniucci.The American Journal of Cardiology . 2009 (7)

[7]

2009 Focused Updates: ACC/AHA Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction (Updating the 2004 Guideline and 2007 Focused Update) and ACC/AHA/SCAI Guidelines on Percutaneous Coronary Intervention (Updating the 2005 Guideline and 2007 Focused Update)[J] . Frederick G. Kushner,Mary Hand,Sidney C. Smith,Spencer B. King,Jeffrey L. Anderson,Elliott M. Antman,Steven R. Bailey,Eric R. Bates,James C. Blankenship,Donald E. Casey,Lee A. Green,Judith S. Hochman,Alice K.

[8] Serial Assessment of Left Ventricular Remodeling and Function by Echo-Tissue Doppler Imaging After Myocardial Infarction in Streptozotocin-Induced Diabetic Swine [J].

Ruan, Wen ;

Lu, Lin ;

Zhang, Qi ;

Cao, Min ;

Bin Zhu, Zheng ;

Wang, Ling Jie ;

Shen, Wei Feng .

JOURNAL OF THE AMERICAN SOCIETY OF ECHOCARDIOGRAPHY, 2009, 22 (05) :530-536

[9] Pharmacological Intervention for Prevention of Left Ventricular Remodeling and Improving Prognosis in Myocardial Infarction [J].

Ishii, Hideki ;

Amano, Tetsuya ;

Matsubara, Tatsuaki ;

Murohara, Toyoaki .

CIRCULATION, 2008, 118 (25) :2710-2718

[10]

Clinical End Points in Coronary Stent Trials: A Case for Standardized Definitions[J] . Donald E. Cutlip,Stephan Windecker,Roxana Mehran,Ashley Boam,David J. Cohen,Gerrit-Anne van Es,P Gabriel Steg,Marie-angèle Morel,Laura Mauri,Pascal Vranckx,Eugene McFadden,Alexandra Lansky,Martial Hamon,Mitchell W. Krucoff,Patrick W. Serruys.Circulation . 2007 (17)

← 1 2 →